Company / Profit Margin
AMICUS THERAPEUTICS, INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4.3%
FY2025
5-year range
-82.0% / -4.3%
FY2021-FY2025
Trend
+59.8%
vs FY2024
Sector context
#62 of 146
Health Care
What the data says
At -4.3%, AMICUS THERAPEUTICS, INC.'s profit margin ranks #62 of 146 in the Health Care sector. Profit Margin has increased for 8 consecutive years, from -4034.7% in FY2016 to -4.3% in FY2025.
Based on SEC 10-K filings.
-4.3% in FY2025 with a 5-year CAGR of +101.8%.
Improved from -38.0% to -4.3% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +67.6pp
- 5-Year Change
- +101.8pp
- 10-Year Change
- -
Sector benchmark
#62 of 146 in Health CareTop 42% of 146This company -4.3% Sector average -796.3%
▼
+99.5% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s profit margin has grown for 6 consecutive years.
- In FY2025, profit margin increased 59.8% year-over-year.
- Currently 792.0pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.3% | +59.8% |
| FY2024 | -10.6% | +72.0% |
| FY2023 | -38.0% | +47.2% |
| FY2022 | -71.9% | +12.4% |
| FY2021 | -82.0% | +22.7% |
| FY2020 | -106.1% | +45.7% |
| FY2019 | -195.6% | - |
| FY2018 | - | - |
| FY2017 | -769.0% | +80.9% |
| FY2016 | -4034.7% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026